Mar 7, 2016 • 7:35 am EST Corbus Pharmaceuticals Expands Clinical Development of Resunab(TM) With Phase 2 Trial for the Treatment of Systemic Lupus Erythematosus
Feb 1, 2016 • 7:05 am EST Corbus Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference on February 9, 2016
Jan 5, 2016 • 7:05 am EST Corbus Pharmaceuticals to Present at Biotech Showcase(TM) on January 12, 2016